InvestorsHub Logo
Followers 36
Posts 1166
Boards Moderated 0
Alias Born 03/07/2013

Re: Dr V post# 4190

Thursday, 10/02/2014 10:41:56 AM

Thursday, October 02, 2014 10:41:56 AM

Post# of 118384
With yesterday PR, I'm hoping dCellVax gets approval before HemaX.
Previous PR stated that they need more safety trials for HemaX which could take up to 4 months.

If Ichim and Koos have learned all that is needed for proper IND of dCellVax based on the HemaX IND difficulties, then I hope that yesterday's PR stating that they have all they need for dCellVax IND means it has the possibility of approval first time round, which means it will get priority over HemaX for first trial which is just fine with me. Should dCellVax help cure someone's cancer outright, we have high hopes of RGBP really gaining legs.

Agreed. We need HemaXellerate for the legitimacy it brings to instill confidence in serious investors. Assuming that it will reach clinical trials before dCellVax.